Literature DB >> 12662283

Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim.

Victoria Moncada1, Charles Bolan, Yu Ying Yau, Susan F Leitman.   

Abstract

BACKGROUND: The circulating CD34 count is a reliable predictor of peripheral blood progenitor cell (PBPC) yields in subjects with a vigorous mobilization response to G-CSF, however, the value of this parameter in poor mobilizers is uncharacterized. STUDY DESIGN AND METHODS: Consecutive PBPC procedures (n = 81) with preapheresis CD34 counts less than 20 per microL (poor mobilizers) were compared with an equal number of good mobilizers (preapheresis CD34 counts > or =20/microL). G-CSF was administered at standard doses (10 microg/kg/day).
RESULTS: CD34 yields correlated strongly with preapheresis CD34 counts in both good and poor mobilizers and were higher in allogeneic than autologous donors. For a standard 75-kg recipient, a CD34 cell dose of greater than 2 x 10(6) per kg was never achieved in less than two 15-L procedures if the preapheresis CD34 count was less than 8 per microL. Preapheresis WBC and MNC counts were lower in poor than in good mobilizers (28.4 vs. 43.0 and 3.25 vs. 5.01 x 10(3)/microL, respectively, p < 0.0001). Total WBC counts correlated more strongly with preapheresis CD34 counts, total CD34 yields, and CD34 yields per L processed in good mobilizers (R = 0.50, R = 0.44, and R = 0.42, respectively) than in poor mobilizers (R = 0.22, R = 0.02, and R = 0.01, respectively), whereas total MNC counts correlated more strongly with these parameters in poor (R = 0.38, R = 0.23, and R = 0.27, respectively) than in good mobilizers (R = 0.04, R = 0.13, and R = 0.16, respectively).
CONCLUSION: CD34 cell yields correlate strongly with preapheresis CD34 counts. Based on this analysis, a CD34 count greater than or equal to 8 per microL is the threshold for performing PBPC collections in our institution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662283     DOI: 10.1046/j.1537-2995.2003.00361.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  11 in total

1.  Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.

Authors:  Sandhya R Panch; Yu Ying Yau; Courtney D Fitzhugh; Matthew M Hsieh; John F Tisdale; Susan F Leitman
Journal:  Transfusion       Date:  2016-05       Impact factor: 3.157

2.  A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers.

Authors:  Steven J Lemery; Matthew M Hsieh; Aleah Smith; Sheila Rao; Hanh M Khuu; Donohue Theresa; Jennifer M Viano; Lisa Cook; Rose Goodwin; Carol Boss; Gary Calandra; Nancy Geller; John Tisdale; Richard Childs
Journal:  Br J Haematol       Date:  2011-02-24       Impact factor: 6.998

3.  Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.

Authors:  C Zhang; X-H Chen; X Zhang; L Gao; L Gao; P-Y Kong; X-G Peng; A-H Sun; Y Gong; D-F Zeng; Q-Y Wang
Journal:  Transfus Med       Date:  2010-02-01       Impact factor: 2.019

4.  Large volume leukapheresis is efficient and safe even in small children up to 15 kg body weight.

Authors:  Ines Bojanic; Sanja Mazic; Ljubica Rajic; Gordana Jakovljevic; Jasminka Stepan; Branka Golubic Cepulic
Journal:  Blood Transfus       Date:  2016-01-13       Impact factor: 3.443

5.  Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

Authors:  Sumithira Vasu; Susan F Leitman; John F Tisdale; Matthew M Hsieh; Richard W Childs; A John Barrett; Daniel H Fowler; Michael R Bishop; Elizabeth M Kang; Harry L Malech; Cynthia E Dunbar; Hanh M Khuu; Robert Wesley; Yu Y Yau; Charles D Bolan
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

Review 6.  Allogeneic peripheral blood stem cell collection as of 2008.

Authors:  Beverly Rhodes; Paolo Anderlini
Journal:  Transfus Apher Sci       Date:  2008-05-22       Impact factor: 1.764

7.  Prediction model for CD34 positive cell yield in peripheral blood stem cell collection on the fourth day after G-CSF administration in healthy donors.

Authors:  Tetsuichi Yoshizato; Naoko Watanabe-Okochi; Yasuhito Nannya; Motoshi Ichikawa; Tsuyoshi Takahashi; Tomohiko Sato; Akiko Masuda; Yutaka Yatomi; Nelson Hirokazu Tsuno; Mineo Kurokawa; Koki Takahashi
Journal:  Int J Hematol       Date:  2013-05-22       Impact factor: 2.490

8.  Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.

Authors:  Abba C Zubair; Rhonda Grant; Wenting Wu; Han Tun; Candido Rivera; Alvaro Moreno-Aspitia; Michael Joyce; Vivek Roy; Gerardo Colon-Otero; Lawrence A Solberg
Journal:  Transfusion       Date:  2008-02-25       Impact factor: 3.157

9.  Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.

Authors:  Halvard Bonig; Doreen Chudziak; Greg Priestley; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2009-01-20       Impact factor: 3.084

10.  Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.

Authors:  Andreas Lundqvist; Aleah L Smith; Yoshiyuki Takahashi; Susan Wong; Erkut Bahceci; Lisa Cook; Catalina Ramos; Abdul Tawab; J Philip McCoy; Elizabeth J Read; Hanh M Khuu; Charles D Bolan; Jungnam Joo; Nancy Geller; Susan F Leitman; Gary Calandra; Cynthia Dunbar; Roger Kurlander; Richard W Childs
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.